Studies on the mode of action of pyocin. II. Inactivation of ribosomes.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000096:biosynthesis*; D001430:Bacteriocins / Q000494:pharmacology; D004269:DNA, Bacterial / Q000096:biosynthesis*; D066298:In Vitro Techniques; D009713:Nucleotidyltransferases / Q000378:metabolism; D010649:Phenylalanine / Q000378:metabolism; D011119:Polynucleotides / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D012329:RNA, Bacterial / Q000096:biosynthesis*; D012270:Ribosomes / Q000187:drug effects*; D014461:Ultracentrifugation; D014500:Uracil Nucleotides / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D001430:Bacteriocins; D004269:DNA, Bacterial; D011119:Polynucleotides; D012329:RNA, Bacterial; D014500:Uracil Nucleotides; D010649:Phenylalanine; D009713:Nucleotidyltransferases